For IPO Boutique's "scale of 1 to 5" BUY rating on Lucid, Inc., and our comprehensive analysis, click the "Buy Market Research" link.
About Lucid, Inc. (adapted from Lucid, Inc. prospectus): Lucid is a medical device and information technology company that designs, manufactures and sells non-invasive imaging devices, known as the VivaScope 1500 and VivaScope 3000 confocal imagers. They designed these imaging devices to assist physicians in the early detection and diagnosis of melanoma, basal cell carcinoma, and squamous cell carcinoma, thereby frequently eliminating biopsies of benign lesions. VivaScopes use a non-invasive technique to produce high-resolution cellular images of a skin lesion (i.e. a "virtual biopsy") for subsequent diagnostic review by pathologists. These devices have received FDA 510(k) clearance as the VivaScope System.
This description is adapted from Lucid prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus..
Share this IPO Profile:
IPO Boutique aggregates information on public companies and private companies, such as Lucid "LUCD" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.